In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Shubham Pant, MD
Professor, Dept of GI Medical Oncology
UT MD Anderson Cancer Center
Houston, TX
Dr. Pant has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research support: Lilly, Mirati Therapeutics, Novartis, Xencor
Consulting fees: AskGene, Ipsen, Janssen, Novartis, Zymeworks
Ritu Salani, MD
Professor, Division Director
University of California, Los Angeles
Los Angeles, CA
Dr. Salani has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research support: GSK, Merck, Verastem
Consulting fees: Eisai, GSK, ImmunoGen, Karyopharm, Merck, Regeneron, Seagen
Reviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Bing-E Xu has nothing to disclose.